SETH SANDESH

Insider CIK 1566175 · ATNM Executive Chairman, Director · RLMD Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ATNM Actinium Pharmaceuticals,	A Award deriv	2026-09-02	2026-09-04	1,130,400	—	$0	1,130,400	SEC↗
ATNM Actinium Pharmaceuticals,	A Award	2026-09-02	2026-09-04	753,600	—	$0	938,081	SEC↗
ATNM Actinium Pharmaceuticals,	A Award	2026-09-02	2026-09-04	1,027,274	—	$0	1,965,355	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2026-09-02	2026-09-04	1,130,400	—	$0	1,130,400	SEC↗
ATNM Actinium Pharmaceuticals,	A Award	2026-09-02	2026-09-04	1,027,274	—	$0	1,965,355	SEC↗
ATNM Actinium Pharmaceuticals,	A Award	2026-09-02	2026-09-04	753,600	—	$0	938,081	SEC↗
ATNM Actinium Pharmaceuticals,	F Tax w/h	2025-08-18	2025-08-20	120,900	$1.71	$206.7K	184,481	SEC↗
ATNM Actinium Pharmaceuticals,	D To issuer deriv	2025-03-31	2025-04-02	827,366	—	$0	0	SEC↗
ATNM Actinium Pharmaceuticals,	D To issuer deriv	2025-03-31	2025-04-02	25,000	—	$0	0	SEC↗
ATNM Actinium Pharmaceuticals,	D To issuer deriv	2025-03-31	2025-04-02	16,666	—	$0	0	SEC↗
ATNM Actinium Pharmaceuticals,	D To issuer deriv	2025-03-31	2025-04-02	984,367	—	$0	0	SEC↗
ATNM Actinium Pharmaceuticals,	D To issuer deriv	2025-03-31	2025-04-02	33,333	—	$0	0	SEC↗
ATNM Actinium Pharmaceuticals,	D To issuer deriv	2025-03-31	2025-04-02	50,000	—	$0	0	SEC↗
ATNM Actinium Pharmaceuticals,	D To issuer deriv	2025-03-31	2025-04-02	139,062	—	$0	0	SEC↗
ATNM Actinium Pharmaceuticals,	D To issuer deriv	2025-03-31	2025-04-02	310,182	—	$0	0	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2023-12-28	2023-12-29	984,367	—	$0	984,367	SEC↗
ATNM Actinium Pharmaceuticals,	A Award	2022-08-17	2022-08-19	300,000	—	$0	305,381	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2022-07-01	2022-07-01	827,366	—	$0	827,366	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2021-09-01	2021-09-03	310,182	—	$0	310,182	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2020-08-12	2020-08-14	139,062	—	$0	139,062	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2019-07-12	2019-07-16	1,500,000	$0.23	$345.0K	1,500,000	SEC↗
ATNM Actinium Pharmaceuticals,	X Exercise	2019-02-21	2019-02-21	8,125	$0.60	$4.9K	161,458	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2018-12-10	2018-12-10	10,000	$0.44	$4.4K	153,333	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2018-07-17	2018-07-17	10,000	$0.79	$7.9K	143,333	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2018-07-13	2018-07-17	1,000,000	$0.78	$780.0K	1,000,000	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2018-04-19	2018-04-20	5,000	$0.38	$1.9K	133,333	SEC↗
ATNM Actinium Pharmaceuticals,	J Other deriv	2018-03-06	2018-03-08	13,125	$0.50	$6.6K	13,125	SEC↗
ATNM Actinium Pharmaceuticals,	J Other deriv	2018-03-06	2018-03-08	39,375	$0.50	$19.7K	39,375	SEC↗
ATNM Actinium Pharmaceuticals,	J Other	2018-03-06	2018-03-08	52,500	$0.50	$26.3K	128,333	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2017-08-02	2017-08-04	33,333	$0.75	$25.0K	75,833	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2017-06-15	2017-06-15	2,500	$1.17	$2.9K	37,500	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2017-06-15	2017-06-15	5,000	$1.16	$5.8K	42,500	SEC↗
ATNM Actinium Pharmaceuticals,	J Other deriv	2017-03-14	2017-03-16	57,212	$2.34	$133.9K	0	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2017-03-14	2017-03-16	57,212	$2.34	$133.9K	57,212	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2017-03-14	2017-03-16	750,000	$1.39	$1.04M	750,000	SEC↗
ATNM Actinium Pharmaceuticals,	J Other deriv	2017-03-14	2017-03-16	99,619	$0.78	$77.7K	100	SEC↗
ATNM Actinium Pharmaceuticals,	J Other deriv	2017-03-14	2017-03-16	64,746	$0.78	$50.5K	64,746	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2016-12-30	2017-01-03	5,000	$0.88	$4.4K	35,000	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2016-12-12	2016-12-12	5,000	$0.98	$4.9K	30,000	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2016-04-18	2016-04-18	1,500	$1.99	$3.0K	25,000	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2016-04-18	2016-04-18	5,000	$1.98	$9.9K	23,500	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2016-04-15	2016-04-18	500,000	$1.99	$995.0K	500,000	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2016-04-15	2016-04-18	1,500	$2.01	$3.0K	18,500	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2016-04-15	2016-04-18	2,000	$2.00	$4.0K	17,000	SEC↗
ATNM Actinium Pharmaceuticals,	P Buy	2016-04-14	2016-04-18	5,000	$2.00	$10.0K	15,000	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-15	2015-12-17	2,400	$3.50	$8.4K	123,258	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-15	2015-12-17	2,500	$3.00	$7.5K	116,258	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-15	2015-12-17	2,000	$2.91	$5.8K	118,258	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-15	2015-12-17	2,500	$3.30	$8.3K	120,758	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-15	2015-12-17	100	$3.43	$343	120,858	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-14	2015-12-16	1,560	$2.89	$4.5K	105,758	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-14	2015-12-16	800	$2.50	$2.0K	104,058	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-14	2015-12-16	140	$2.50	$350	104,198	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-14	2015-12-16	5,000	$2.99	$15.0K	112,258	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-14	2015-12-16	1,000	$2.97	$3.0K	107,258	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-14	2015-12-16	500	$2.90	$1.4K	106,258	SEC↗
RLMD RELMADA THERAPEUTICS, INC.	P Buy	2015-12-14	2015-12-16	1,500	$3.00	$4.5K	113,758	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2014-09-23	2015-03-16	150,000	$3.58	$537.0K	150,000	SEC↗
ATNM Actinium Pharmaceuticals,	A Award deriv	2014-09-23	2014-09-25	280,000	$6.13	$1.72M	204,853	SEC↗
ATNM Actinium Pharmaceuticals,	A Award	2013-08-08	2013-12-24	10,000	$3.60	$36.0K	0	SEC↗
ATNM Actinium Pharmaceuticals,	J Other deriv	2013-07-25	2013-08-22	721,068	$0.01	$7.2K	178,350	SEC↗